Remicade News
Most Popular Remicade Story
MAbs are hottest segment of biotech industry
Looking for the hottest segment of the biotech industry? Then take a look at monoclonal antibodies (mAbs). A new Datamonitor report projects 14 percent annual growth in the market for the antibody Read more...
Latest Headlines
- October 3, 2008
- November 8, 2007
- October 12, 2007
- February 1, 2007
- October 26, 2006
- August 13, 2006
- March 8, 2006
- December 19, 2005
- October 13, 2005
- August 15, 2005
- August 11, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
